论文部分内容阅读
近年来,由于对血液动力学的研究,血管扩张药为心血管疾病的治疗开拓了新的途径。血管扩张剂硝普钠用于心血管疾病的治疗日趋普遍,多数用于高血压危象、冠心病,而对肺心病右心衰竭的血液动力学影响尚在探索阶段,对其治疗评价还有争议。从1982年起,我们以“全国第二次肺心病专业会议诊断标准”为依据,选择慢性肺源性心脏病右心衰竭患者,经综合治疗(抗感染、祛痰、扩张支气管、吸氧、利尿、血管扩张剂消心痛、654—2等),肺部感染已控制、而右心衰竭尚难以控制的患者,用硝普钠治疗。现将资料较完整的10例的治疗体会介绍如下。硝普钠的使用方法:将硝普钠干粉50mg溶于500ml葡萄糖内成为每ml含100ug的溶液(除葡萄糖液不能用其他稀释剂,也不能加入其它药物)硝普钠对光敏感,输液需用黑
In recent years, vasodilators have opened new avenues for the treatment of cardiovascular diseases due to their studies on hemodynamics. Vasodilator sodium nitroprusside for the treatment of cardiovascular disease is becoming more common, mostly used for hypertensive crisis, coronary heart disease, and pulmonary heart disease, right heart failure hemodynamic effects are still in the exploratory stage, the evaluation of its treatment dispute. From 1982 onwards, we selected patients with right heart failure due to chronic cor pulmonale based on the “Diagnostic Criteria for the Second Conference of National Pulmonary Heart Disease Conferences”. After comprehensive treatment (anti-infective, expectorant, bronchial expansion, oxygen inhalation, Diuretic, vasodilator, antinociceptive pain, 654-2, etc.), pulmonary infection has been controlled, and right heart failure is still difficult to control patients treated with sodium nitroprusside. The information is more complete treatment of 10 cases described below. Sodium nitroprusside use: sodium nitroprusside powder 50mg dissolved in 500ml of glucose into a solution containing 100ug per ml (except glucose solution can not be used with other diluents, nor can add other drugs) sodium nitroprusside light-sensitive infusion required Use black